Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary
Author:
Urrutia María-Teresa1ORCID, Araya Alejandra-Ximena1, Gajardo Macarena2, Chepo Macarena1ORCID, Torres Romina3, Schilling Andrea4ORCID
Affiliation:
1. School of Nursing, Universidad Andrés Bello, Santiago 8370134, Chile 2. School of Medicine, Universidad de Chile, Santiago 9170022, Chile 3. Sistema de Bibliotecas UC, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile 4. Clinical Research Center, Institute of Science and Innovation in Medicine, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago 7610315, Chile
Abstract
In 2006, the human papillomavirus (HPV) vaccine was approved for use as an effective intervention for reducing the risk of developing cervical cancer; however, its successful implementation is dependent on acceptability. This study aims to provide a comprehensive understanding of the reasons that favor or do not favor the acceptability of HPV vaccines. Methods: We conducted a systematic review and meta-summary of qualitative research on 16 databases. A total of 32 articles that considered the perspectives of vaccine users, their parents, and the professionals who care for them were reviewed. Synthesis was conducted as described by Sandelowski and Barroso. Results: We used inductive and deductive methods to obtain a total of 22 dimensions, out of which three issues stood out that should be considered to improve acceptability and are formed by three groups of study, namely, information about the vaccine, fears and side effects, and sexuality associated with the vaccine. Conclusions: Acceptability, as well as adherence to HPV vaccination, is a complex concept. This review highlights the perspectives of the three sets of actors involved in the process (i.e., users, parents, and professionals) and views these factors in relation to acceptability as a guide for new interventions.
Funder
Fondo Nacional de Investigación en Salud-Chile/National Fund for Health Research
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference68 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021 2. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., Muñoz, J., Bosch, F.X., and de Sanjosé, S. (2023, July 26). ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. Available online: https://hpvcentre.net/statistics/reports/ZAF.pdf?t=1668367618799. 3. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis;Drolet;Lancet,2019 4. World Health Organization (2022, June 14). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva 2020. Licence: CC BY-NC-SA 3.0 IGO. Available online: https://www.who.int/publications/i/item/9789240014107. 5. An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy;Yousefi;Front. Immunol.,2022
|
|